SCHEMBL18586609

SCHEMBL18586609

CS(=O)(=O)CCc1cc(C(F)(F)F)ccc1Br

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DAO P14920 3/20 0.36
TAS2R14 Q9NYV8 1/20 0.36
ALDH1A1 P00352 2/20 0.35
HSD17B10 Q99714 2/20 0.35
KDM4E B2RXH2 1/20 0.35
HPGD P15428 1/20 0.35
MCL1 Q07820 1/20 0.35
DHFR P00374 1/20 0.34
KIF11 P52732 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
PTGS2 P35354 1/20 0.34
TRPV1 Q8NER1 1/20 0.34
MMP1 P03956 2/20 0.33
IDO1 P14902 1/20 0.33
PIEZO1 Q92508 1/20 0.33
ADRA1A P35348 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4597627 0.78 PPARG (0.40) DAOALDH1A1KDM4EKIF11IDO1
SCHEMBL17742275 0.78 ESR1 (0.40) DAOTAS2R14IDO1PIEZO1
SCHEMBL1601756 0.77 MMP1 (0.38) TAS2R14ALDH1A1HSD17B10KDM4EHPGD
SCHEMBL15820309 0.77 KMT2A (0.40) KDM4EKIF11CA1CA2PTGS2
SCHEMBL27705804 0.76 PTPN1 (0.39) DAOTAS2R14IDO1PIEZO1
SCHEMBL18586260 0.76 IDO1 (0.39) DAOTAS2R14IDO1PIEZO1
SCHEMBL3410622 0.75 IDO1 (0.42) DAOTAS2R14IDO1PIEZO1
SCHEMBL4680952 0.74 IDO1 (0.40) DAOTAS2R14ALDH1A1HSD17B10KDM4E
SCHEMBL2928941 0.74 ACLY (0.39) TAS2R14KIF11CA1CA2MMP1
SCHEMBL271228 0.74 KIF11 (0.39) TAS2R14KIF11CA1CA2PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10239869-B2 Sulfonamide compounds as voltage-gated sodium channel modulators LUPIN LIMITED (IN) 2019-03-26 US disclosed
US-10239869-B2 Sulfonamide compounds as voltage-gated sodium channel modulators LUPIN LIMITED (IN) 2019-03-26 US disclosed
EP-3344621-A1 SULFONAMIDE COMPOUNDS AS VOLTAGE-GATED SODIUM CHANNEL MODULATORS Lupin Limited (IN) 2018-07-11 EP disclosed
US-20180186777-A1 SULFONAMIDE COMPOUNDS AS VOLTAGE-GATED SODIUM CHANNEL MODULATORS LUPIN LIMITED (IN) 2018-07-05 US disclosed
US-20180186777-A1 SULFONAMIDE COMPOUNDS AS VOLTAGE-GATED SODIUM CHANNEL MODULATORS LUPIN LIMITED (IN) 2018-07-05 US disclosed
US-20180186777-A1 SULFONAMIDE COMPOUNDS AS VOLTAGE-GATED SODIUM CHANNEL MODULATORS LUPIN LIMITED (IN) 2018-07-05 US disclosed
WO-2017037682-A1 SULFONAMIDE COMPOUNDS AS VOLTAGE-GATED SODIUM CHANNEL MODULATORS LUPIN LIMITED (IN) 2017-03-09 WO disclosed
WO-2017037682-A1 SULFONAMIDE COMPOUNDS AS VOLTAGE-GATED SODIUM CHANNEL MODULATORS LUPIN LIMITED (IN) 2017-03-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10239869-B2 Sulfonamide compounds as voltage-gated sodium channel modulators SCN7A, SCN1A, SCN5A DAO 4247/4885TAS2R14 571/4885ALDH1A1 1647/4885
US-20180186777-A1 SULFONAMIDE COMPOUNDS AS VOLTAGE-GATED SODIUM CHANNEL MODULATORS SCN7A, SCN1A, SCN5A DAO 4247/4885TAS2R14 571/4885ALDH1A1 1647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.